Diagnostic yield of TBNA and bronchial biopsy in lung cancer

Authors

  • Anita Kumari Department of Pathology, J. L. N. Medical College, Ajmer, Rajasthan, India
  • Madhu Gupta Department of Pathology, Dr. S. N. Medical College, Jodhpur, Rajasthan, India
  • . Abhesheik Department of Orthopaedics, Fortis Escort Hospital, Jaipur, Rajasthan, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20173590

Keywords:

Bronchogenic carcinoma, Forceps biopsy, TBNA, Yield

Abstract

Background: Lung cancer has been the most common cancer worldwide since 1985, both in terms of incidence and mortality.  In India, approximately 63,000 new lung cancer cases are reported each year. The study was undertaken to detect diagnostic yield of bronchial biopsy and transbronchial needle aspiration in suspected cases of bronchogenic carcinoma.

Methods: This was a prospective study including 57 patients having clinical and radiological features of malignancy. Endobronchial forceps biopsy (FB) and transbronchial needle aspiration cytology (TBNA) has been employed during fiber-optic bronchoscopy. The statistical analysis was done using chi-square test.

Results: Out of total 57 patients, 43 were found malignant on FB plus TBNA. The majority of patients (59.45%) were found to have squamous cell carcinoma on biopsy followed by Adenocarcinoma (16.21%), Small cell carcinoma (13.51%) and untypable cases (10.81%). On TBNA majority of patients (41.93%) could not be typed into any of the specific subtype. Out of rest typable carcinoma majority were squamous cell carcinoma (35.48%). Sensitivity of TBNA in diagnosing lung malignancy was 67.6%. The yield of TBNA, FB and TBNA plus FB was 54.38%, 64.91% and 75.43% respectively. Additional yield of TBNA over FB was 10.52%.

Conclusions: TBNA is a beneficial, safe and minimally invasive bronchoscopic technique and may be considered routinely during Fiberoptic Bronchoscopy procedure to increase the yield with insignificant side effects in the diagnosis of bronchogenic carcinoma.

References

Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893-917.

Bobba R, Khan Y. Cancer in India: An overview. GOR. 2003;5(4):93-6.

U.S. Public Health Service, office of the Surgeon General: The health consequences of smoking. National Clearinghouse for Smoking Health. 1972.

Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin. 1999;49:33-64.

Siegel R, Ward E, Brawley O. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61(4):212-36.

Govert JA, Dodd LG, Kussin PS, Samuelson WM. A prospective comparison of fiberoptic transbronchial needle aspiration and bronchial biopsy for bronchoscopically visible lung combinations of sampling technique. BMC. 2008;8:2.

Mazzone P, Jain P, Arroliga AC, Matthay RA. Bronchoscopic and needle biopsy techniques for diagnosis and staging of lung cancer. Clin Chest Med. 2002;23:137-58.

Descombes E, Gardiol D, Leuenberger P. Transbronchial lung biopsy: an analysis of 530 cases with reference to the number of samples. Monaldi Arch Chest Dis. 1997;52:324-9.

Popovich Jr J, Kvale PA, Eichenhorn MS, Radke JR, Ohorodnik JM, Fine G. Diagnostic accuracy of multiple biopsies from flexible fiberoptic bronchoscopy. A comparison of central versus peripheral carcinoma. Am Rev Respir Dis. 1982;125:521-3.

Atlanta GA. American Cancer Society; 2014, Cancer Facts & Figures 2014. Available at https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2014/cancer-facts-and-figures-2014.pdf.

Spiro SG, Porter JC. Lung cancer-where are we today? Current advances in staging and nonsurgical treatment. Am J Respir Crit Care Med. 2002;166:1166-96.

Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin. 2003;53(1):27-43.

Bayram B, Borekci S, Uyar M, Bakir K, Elbek O. Transbronchial needle aspiration in the diagnosis and staging of lung cancer. Indian J Chest Dis Allied Sci. 2008;50:273-6.

Zhu B, Maldonado F, Bungum ao, Eric S. Sensitivity and specificity of TBNA in a large academic center: P1-104 J Thoracic Oncol. 2007;2(8):591.

Salathe M, Soler M, Bolinger CT. Transbronchial needle Aspiration in routine fiberoptic bronchoscopy. Respiration. 1992;59:5-8.

Caglayan B, Akturk UA, Fidan A, Salepci B, Ozdogan S, Sarac G et al. Transbronchial needle aspiration in the diagnosis of endobronchial malignant lesions: a 3-year experience. Chest. 2005;128(2):704-8.

Gullon JA, Fernandez R, Medina A, Rubinos G, Suárez I, Ramos C, et al. Transbronchial needle aspiration in bronchogenic carcinoma with visible lesions: diagnostic yield and cost. Arch Bronconeumol. 2003;39:496-500.

Roth K, Hardie JA, Andreassen AH, Leh F, Eagan TM. Predictors of diagnostic yield in bronchoscopy: a retrospective cohort study comparing different combinations of sampling techniques. BMC Pulmonary Med. 2008;8(1):2.

Downloads

Published

2017-07-26

How to Cite

Kumari, A., Gupta, M., & Abhesheik, . (2017). Diagnostic yield of TBNA and bronchial biopsy in lung cancer. International Journal of Research in Medical Sciences, 5(8), 3708–3712. https://doi.org/10.18203/2320-6012.ijrms20173590

Issue

Section

Original Research Articles